Literature DB >> 9384579

Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

M P Crump1, J H Gong, P Loetscher, K Rajarathnam, A Amara, F Arenzana-Seisdedos, J L Virelizier, M Baggiolini, B D Sykes, I Clark-Lewis.   

Abstract

The three-dimensional structure of stromal cell-derived factor-1 (SDF-1) was determined by NMR spectroscopy. SDF-1 is a monomer with a disordered N-terminal region (residues 1-8), and differs from other chemokines in the packing of the hydrophobic core and surface charge distribution. Results with analogs showed that the N-terminal eight residues formed an important receptor binding site; however, only Lys-1 and Pro-2 were directly involved in receptor activation. Modification to Lys-1 and/or Pro-2 resulted in loss of activity, but generated potent SDF-1 antagonists. Residues 12-17 of the loop region, which we term the RFFESH motif, unlike the N-terminal region, were well defined in the SDF-1 structure. The RFFESH formed a receptor binding site, which we propose to be an important initial docking site of SDF-1 with its receptor. The ability of the SDF-1 analogs to block HIV-1 entry via CXCR4, which is a HIV-1 coreceptor for the virus in addition to being the receptor for SDF-1, correlated with their affinity for CXCR4. Activation of the receptor is not required for HIV-1 inhibition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9384579      PMCID: PMC1170303          DOI: 10.1093/emboj/16.23.6996

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

2.  The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation.

Authors:  F S Monteclaro; I F Charo
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

3.  HIV-1 subtype and second-receptor use.

Authors:  L Zhang; Y Huang; T He; Y Cao; D D Ho
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

4.  HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5.

Authors:  M Farzan; H Choe; K A Martin; Y Sun; M Sidelko; C R Mackay; N P Gerard; J Sodroski; C Gerard
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

5.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.

Authors:  E Oberlin; A Amara; F Bachelerie; C Bessia; J L Virelizier; F Arenzana-Seisdedos; O Schwartz; J M Heard; I Clark-Lewis; D F Legler; M Loetscher; M Baggiolini; B Moser
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

6.  A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.

Authors:  A Gervaix; D West; L M Leoni; D D Richman; F Wong-Staal; J Corbeil
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  1H NMR studies of interleukin 8 analogs: characterization of the domains essential for function.

Authors:  K Rajarathnam; I Clark-Lewis; B D Sykes
Journal:  Biochemistry       Date:  1994-05-31       Impact factor: 3.162

8.  Fusion from without directed by human immunodeficiency virus particles.

Authors:  F Clavel; P Charneau
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Backbone 1H and 15N resonance assignments of the N-terminal SH3 domain of drk in folded and unfolded states using enhanced-sensitivity pulsed field gradient NMR techniques.

Authors:  O Zhang; L E Kay; J P Olivier; J D Forman-Kay
Journal:  J Biomol NMR       Date:  1994-11       Impact factor: 2.835

10.  Molecular cloning and structure of a pre-B-cell growth-stimulating factor.

Authors:  T Nagasawa; H Kikutani; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

View more
  251 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  Characterization of Nef-CXCR4 interactions important for apoptosis induction.

Authors:  Ming-Bo Huang; Ling Ling Jin; Cleve O James; Mahfuz Khan; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction.

Authors:  Vikas Saini; Adriano Marchese; Wei-Jen Tang; Matthias Majetschak
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

Review 4.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

5.  Processing of CXCL12 by different osteoblast-secreted cathepsins.

Authors:  Nicole D Staudt; Andreas Maurer; Bärbel Spring; Hubert Kalbacher; Wilhelm K Aicher; Gerd Klein
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

Review 6.  Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells.

Authors:  Aysegul Ocal Sahin; Miranda Buitenhuis
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

7.  Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.

Authors:  Prem Raj B Joseph; Jose M Sarmiento; Anurag K Mishra; Sandhya T Das; Roberto P Garofalo; Javier Navarro; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2010-07-14       Impact factor: 5.157

8.  CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.

Authors:  Tao Sun; Scott M Gianino; Erin Jackson; David Piwnica-Worms; David H Gutmann; Joshua B Rubin
Journal:  J Neuroimmunol       Date:  2010-07-27       Impact factor: 3.478

9.  The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.

Authors:  Stéphanie Gravel; Camille Malouf; Philip E Boulais; Yamina A Berchiche; Shinya Oishi; Nobutaka Fujii; Richard Leduc; Daniel Sinnett; Nikolaus Heveker
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

10.  The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin.

Authors:  Christopher T Veldkamp; Francis C Peterson; Adam J Pelzek; Brian F Volkman
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.